ATE419004T1 - Vakzine-zusammensetzung mit interleukin-15 (il- 15) - Google Patents

Vakzine-zusammensetzung mit interleukin-15 (il- 15)

Info

Publication number
ATE419004T1
ATE419004T1 AT03757652T AT03757652T ATE419004T1 AT E419004 T1 ATE419004 T1 AT E419004T1 AT 03757652 T AT03757652 T AT 03757652T AT 03757652 T AT03757652 T AT 03757652T AT E419004 T1 ATE419004 T1 AT E419004T1
Authority
AT
Austria
Prior art keywords
interleukin
vaccine composition
vaccine
composition
Prior art date
Application number
AT03757652T
Other languages
English (en)
Inventor
Savio Alicia Santos
Rodr Guez Ricardo Silva
Diaz Yanelis Morera
Guez Alfonso Armando Rodr
Nez Castillo Jose Mart
Nimo P Rez Haydee Ger
Soria Alejandro Moro
Rodr Guez Silvio Perea
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Application granted granted Critical
Publication of ATE419004T1 publication Critical patent/ATE419004T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03757652T 2002-10-09 2003-10-08 Vakzine-zusammensetzung mit interleukin-15 (il- 15) ATE419004T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20020218A CU23093A1 (es) 2002-10-09 2002-10-09 Composición vacunal que comprende interleucina-15 (il-15)

Publications (1)

Publication Number Publication Date
ATE419004T1 true ATE419004T1 (de) 2009-01-15

Family

ID=32078034

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03757652T ATE419004T1 (de) 2002-10-09 2003-10-08 Vakzine-zusammensetzung mit interleukin-15 (il- 15)

Country Status (13)

Country Link
US (1) US8007776B2 (de)
EP (1) EP1550457B1 (de)
JP (1) JP2006507260A (de)
KR (1) KR20050074957A (de)
CN (1) CN100540050C (de)
AR (1) AR041540A1 (de)
AT (1) ATE419004T1 (de)
AU (1) AU2003273725A1 (de)
CU (1) CU23093A1 (de)
DE (1) DE60325619D1 (de)
ES (1) ES2319981T3 (de)
SI (1) SI1550457T1 (de)
WO (1) WO2004032956A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23472A1 (es) * 2004-09-17 2009-12-17 Ct Ingenieria Genetica Biotech Péptido antagonista de la interleucina-15
WO2007008671A2 (en) * 2005-07-07 2007-01-18 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for treating fus1 related disorders
SE532249C2 (sv) * 2006-11-13 2009-11-24 Theravac Pharmaceuticals Ab Nya formuleringar av IL-18 för behandling av olika inflammatoriska sjukdomar genom vaccinering
CN102266551B (zh) * 2011-06-27 2015-05-13 刘永庆 可用于治疗人或动物免疫相关性疾病的白介素-4治疗性疫苗
CU24546B1 (es) 2016-12-30 2021-09-07 Ct Ingenieria Genetica Biotecnologia Composición vacunal que comprende un mutante de la interleucina-15 humana
CA3150224A1 (en) 2019-09-10 2021-03-18 Obsidian Therapeutics, Inc. Ca2 compositions and methods for tunable regulation
WO2022152939A1 (en) 2021-01-18 2022-07-21 Conserv Bioscience Limited Coronavirus immunogenic compositions, methods and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747024A (en) * 1993-03-08 1998-05-05 Immunex Corporation Vaccine adjuvant comprising interleukin-15
CA2261433A1 (en) 1993-12-09 1995-06-10 Belinda Sanchez Ramirez Composition comprising autologous epidermal growth factor
PT772624E (pt) * 1994-04-06 2001-03-30 Immunex Corp Interleucina-15
US5795966A (en) * 1995-02-22 1998-08-18 Immunex Corp Antagonists of interleukin-15
DK1273304T4 (da) * 1997-02-21 2009-08-31 Amgen Inc Anvendelse af interleukin-15
GB9814892D0 (en) * 1998-07-10 1998-09-09 Kennedy Rheumatology Inst Treatment of celiac disease

Also Published As

Publication number Publication date
AR041540A1 (es) 2005-05-18
EP1550457B1 (de) 2008-12-31
US8007776B2 (en) 2011-08-30
CN100540050C (zh) 2009-09-16
US20060182713A1 (en) 2006-08-17
CN1703239A (zh) 2005-11-30
ES2319981T3 (es) 2009-05-18
EP1550457A1 (de) 2005-07-06
AU2003273725A1 (en) 2004-05-04
WO2004032956A1 (es) 2004-04-22
KR20050074957A (ko) 2005-07-19
JP2006507260A (ja) 2006-03-02
CU23093A1 (es) 2005-10-19
SI1550457T1 (sl) 2009-06-30
DE60325619D1 (de) 2009-02-12

Similar Documents

Publication Publication Date Title
IS7806A (is) Ónæmisvaldandi samsetning
NO20050132D0 (no) Vaksinesammensetning
ATE553775T1 (de) Impstoffzusammesetzung
IS7547A (is) Ónæmisvaldandi samsetningar
IS7716A (is) Hringlaga heterósambönd
ATE519527T1 (de) Enzym enthaltend orale zusammensetzung mit verbesserter stabilität
DE10393374D2 (de) Zusammensetzung
DE60335716D1 (de) Beschleuniger-zusammensetzung
EP1549135A4 (de) Impfstoffzusammensetzungen und -hilfsstoff
EP1625850A4 (de) Immunostimulans
DK1689869T4 (da) Rekombinant mikroorganisme
SE0500163L (sv) Sammansättning
EP1500603A4 (de) Ausgiessbehälter
DE60328408D1 (de) Impfstoff
SE0300585L (sv) Brevlåda
ATE513564T1 (de) Immunogener rekombinanter antikörper
ATE419004T1 (de) Vakzine-zusammensetzung mit interleukin-15 (il- 15)
ATE504290T1 (de) Zusammensetzungen mit neramexan
EP1561467A4 (de) Zusammensetzung zur wiederherstellung geschädigter haut
DE60200162D1 (de) Härtungszusammensetzung
NO20023199D0 (no) Punktmater
DE60322070D1 (de) Rekombinante bcg-vakzine
DK1680502T3 (da) Rekombinant mikroorganisme
DE50110467D1 (de) Staffelei
DK200200042U3 (da) Trådløs postviser

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties